This Stock’s 4%-Plus Dividend Has Some Risk of Being Cut
Should the company return to positive free cash flow, the dividend will be rock-solid. Until then, you can’t consider it safe.
Read MorePosted by Marc Lichtenfeld, Wealthy Retirement | Jan 31, 2021
Should the company return to positive free cash flow, the dividend will be rock-solid. Until then, you can’t consider it safe.
Read MorePosted by Marc Lichtenfeld, Wealthy Retirement | Jan 28, 2021
In short, while there will likely be some important changes on tax and economic policy down the road, I don’t expect anything drastic in 2021.
Read MorePosted by Marc Lichtenfeld, Wealthy Retirement | Jan 24, 2021
It should have absolutely no problem paying and raising its dividend in 2021. And I expect it will be upgraded to SafetyNet Pro‘s highest rating in a few weeks once the 2020 results are in.
Read MorePosted by Marc Lichtenfeld, Wealthy Retirement | Jan 20, 2021
It’s going to be a big couple of quarters for the biotech sector. If you know where to look, you can make a lot of money.
Read MorePosted by Marc Lichtenfeld, Wealthy Retirement | Jan 17, 2021
If management’s guidance is accurate, there will be plenty of room to pay and raise the dividend in 2021.
Read More